Mylan, Inc. (MYL), a diversified and generic specialty pharmaceutical company, announced on Thursday that the U.S. Food and Drug Administration, or FDA, granted tentative approval for Linezolid Tablets, 600 mg., a generic version of antibiotic Zyvox tablets.
Linezolid is used to treat infections of the skin, bone, blood, lung and respiratory tract, and other tissues.
Zyvox, owned by Pharmacia and Upjohn, Inc., had sales in the U.S. amounting to $422 million for the 12 months ending March 31, 2008, as per IMS Health.
The Canonsburg, Pennsylvania-based Mylan added that currently it has 93 Abbreviated New Drug Applications pending for FDA approval, of which 21 are potential first-to-file opportunities.
MYL closed Wednesday's regular trading at $12.15, up $0.10 on a volume of nearly 4.38 million shares.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.